The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Somatropin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Somatropin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Somatropin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Somatropin include Novo Nordisk, Pfizer, Eli Lilly and Company, GeneScience Pharmaceuticals, Novartis (Sandoz International), Ipsen, LG Life Sciences, Merck and Hoffmann-La Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Somatropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Somatropin.
Report Scope
The Somatropin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Somatropin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Somatropin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Pfizer
Eli Lilly and Company
GeneScience Pharmaceuticals
Novartis (Sandoz International)
Ipsen
LG Life Sciences
Merck
Hoffmann-La Roche
Teva Pharmaceutical Industries
Ferring Pharmaceuticals
Anhui Anke Biotechnology
Segment by Type
Powder
Solvent
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Somatropin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Somatropin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Somatropin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Somatropin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Somatropin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Somatropin include Novo Nordisk, Pfizer, Eli Lilly and Company, GeneScience Pharmaceuticals, Novartis (Sandoz International), Ipsen, LG Life Sciences, Merck and Hoffmann-La Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Somatropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Somatropin.
Report Scope
The Somatropin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Somatropin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Somatropin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Pfizer
Eli Lilly and Company
GeneScience Pharmaceuticals
Novartis (Sandoz International)
Ipsen
LG Life Sciences
Merck
Hoffmann-La Roche
Teva Pharmaceutical Industries
Ferring Pharmaceuticals
Anhui Anke Biotechnology
Segment by Type
Powder
Solvent
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Somatropin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Somatropin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Somatropin Market Overview
1.1 Product Overview and Scope of Somatropin
1.2 Somatropin Segment by Type
1.2.1 Global Somatropin Market Value Comparison by Type (2024-2030)
1.2.2 Powder
1.2.3 Solvent
1.3 Somatropin Segment by Application
1.3.1 Global Somatropin Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Somatropin Market Size Estimates and Forecasts
1.4.1 Global Somatropin Revenue 2019-2030
1.4.2 Global Somatropin Sales 2019-2030
1.4.3 Global Somatropin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Somatropin Market Competition by Manufacturers
2.1 Global Somatropin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Somatropin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Somatropin Average Price by Manufacturers (2019-2024)
2.4 Global Somatropin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Somatropin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Somatropin, Product Type & Application
2.7 Somatropin Market Competitive Situation and Trends
2.7.1 Somatropin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Somatropin Players Market Share by Revenue
2.7.3 Global Somatropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Somatropin Retrospective Market Scenario by Region
3.1 Global Somatropin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Somatropin Global Somatropin Sales by Region: 2019-2030
3.2.1 Global Somatropin Sales by Region: 2019-2024
3.2.2 Global Somatropin Sales by Region: 2025-2030
3.3 Global Somatropin Global Somatropin Revenue by Region: 2019-2030
3.3.1 Global Somatropin Revenue by Region: 2019-2024
3.3.2 Global Somatropin Revenue by Region: 2025-2030
3.4 North America Somatropin Market Facts & Figures by Country
3.4.1 North America Somatropin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Somatropin Sales by Country (2019-2030)
3.4.3 North America Somatropin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Somatropin Market Facts & Figures by Country
3.5.1 Europe Somatropin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Somatropin Sales by Country (2019-2030)
3.5.3 Europe Somatropin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Somatropin Market Facts & Figures by Country
3.6.1 Asia Pacific Somatropin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Somatropin Sales by Country (2019-2030)
3.6.3 Asia Pacific Somatropin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Somatropin Market Facts & Figures by Country
3.7.1 Latin America Somatropin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Somatropin Sales by Country (2019-2030)
3.7.3 Latin America Somatropin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Somatropin Market Facts & Figures by Country
3.8.1 Middle East and Africa Somatropin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Somatropin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Somatropin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Somatropin Sales by Type (2019-2030)
4.1.1 Global Somatropin Sales by Type (2019-2024)
4.1.2 Global Somatropin Sales by Type (2025-2030)
4.1.3 Global Somatropin Sales Market Share by Type (2019-2030)
4.2 Global Somatropin Revenue by Type (2019-2030)
4.2.1 Global Somatropin Revenue by Type (2019-2024)
4.2.2 Global Somatropin Revenue by Type (2025-2030)
4.2.3 Global Somatropin Revenue Market Share by Type (2019-2030)
4.3 Global Somatropin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Somatropin Sales by Application (2019-2030)
5.1.1 Global Somatropin Sales by Application (2019-2024)
5.1.2 Global Somatropin Sales by Application (2025-2030)
5.1.3 Global Somatropin Sales Market Share by Application (2019-2030)
5.2 Global Somatropin Revenue by Application (2019-2030)
5.2.1 Global Somatropin Revenue by Application (2019-2024)
5.2.2 Global Somatropin Revenue by Application (2025-2030)
5.2.3 Global Somatropin Revenue Market Share by Application (2019-2030)
5.3 Global Somatropin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Somatropin Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Somatropin Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Corporation Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly and Company Somatropin Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 GeneScience Pharmaceuticals
6.4.1 GeneScience Pharmaceuticals Corporation Information
6.4.2 GeneScience Pharmaceuticals Description and Business Overview
6.4.3 GeneScience Pharmaceuticals Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GeneScience Pharmaceuticals Somatropin Product Portfolio
6.4.5 GeneScience Pharmaceuticals Recent Developments/Updates
6.5 Novartis (Sandoz International)
6.5.1 Novartis (Sandoz International) Corporation Information
6.5.2 Novartis (Sandoz International) Description and Business Overview
6.5.3 Novartis (Sandoz International) Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis (Sandoz International) Somatropin Product Portfolio
6.5.5 Novartis (Sandoz International) Recent Developments/Updates
6.6 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description and Business Overview
6.6.3 Ipsen Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ipsen Somatropin Product Portfolio
6.6.5 Ipsen Recent Developments/Updates
6.7 LG Life Sciences
6.6.1 LG Life Sciences Corporation Information
6.6.2 LG Life Sciences Description and Business Overview
6.6.3 LG Life Sciences Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LG Life Sciences Somatropin Product Portfolio
6.7.5 LG Life Sciences Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Somatropin Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Hoffmann-La Roche
6.9.1 Hoffmann-La Roche Corporation Information
6.9.2 Hoffmann-La Roche Description and Business Overview
6.9.3 Hoffmann-La Roche Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hoffmann-La Roche Somatropin Product Portfolio
6.9.5 Hoffmann-La Roche Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Corporation Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Pharmaceutical Industries Somatropin Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.11 Ferring Pharmaceuticals
6.11.1 Ferring Pharmaceuticals Corporation Information
6.11.2 Ferring Pharmaceuticals Somatropin Description and Business Overview
6.11.3 Ferring Pharmaceuticals Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ferring Pharmaceuticals Somatropin Product Portfolio
6.11.5 Ferring Pharmaceuticals Recent Developments/Updates
6.12 Anhui Anke Biotechnology
6.12.1 Anhui Anke Biotechnology Corporation Information
6.12.2 Anhui Anke Biotechnology Somatropin Description and Business Overview
6.12.3 Anhui Anke Biotechnology Somatropin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Anhui Anke Biotechnology Somatropin Product Portfolio
6.12.5 Anhui Anke Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Somatropin Industry Chain Analysis
7.2 Somatropin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Somatropin Production Mode & Process
7.4 Somatropin Sales and Marketing
7.4.1 Somatropin Sales Channels
7.4.2 Somatropin Distributors
7.5 Somatropin Customers
8 Somatropin Market Dynamics
8.1 Somatropin Industry Trends
8.2 Somatropin Market Drivers
8.3 Somatropin Market Challenges
8.4 Somatropin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Somatropin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Somatropin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Somatropin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Somatropin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Somatropin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Somatropin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Somatropin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Somatropin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Somatropin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Somatropin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Somatropin, Product Type & Application
Table 12. Global Key Manufacturers of Somatropin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Somatropin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatropin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Somatropin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Somatropin Sales by Region (2019-2024) & (K Units)
Table 18. Global Somatropin Sales Market Share by Region (2019-2024)
Table 19. Global Somatropin Sales by Region (2025-2030) & (K Units)
Table 20. Global Somatropin Sales Market Share by Region (2025-2030)
Table 21. Global Somatropin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Somatropin Revenue Market Share by Region (2019-2024)
Table 23. Global Somatropin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Somatropin Revenue Market Share by Region (2025-2030)
Table 25. North America Somatropin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Somatropin Sales by Country (2019-2024) & (K Units)
Table 27. North America Somatropin Sales by Country (2025-2030) & (K Units)
Table 28. North America Somatropin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Somatropin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Somatropin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Somatropin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Somatropin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Somatropin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Somatropin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Somatropin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Somatropin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Somatropin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Somatropin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Somatropin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Somatropin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Somatropin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Somatropin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Somatropin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Somatropin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Somatropin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Somatropin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Somatropin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Somatropin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Somatropin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Somatropin Sales (K Units) by Type (2019-2024)
Table 51. Global Somatropin Sales (K Units) by Type (2025-2030)
Table 52. Global Somatropin Sales Market Share by Type (2019-2024)
Table 53. Global Somatropin Sales Market Share by Type (2025-2030)
Table 54. Global Somatropin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Somatropin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Somatropin Revenue Market Share by Type (2019-2024)
Table 57. Global Somatropin Revenue Market Share by Type (2025-2030)
Table 58. Global Somatropin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Somatropin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Somatropin Sales (K Units) by Application (2019-2024)
Table 61. Global Somatropin Sales (K Units) by Application (2025-2030)
Table 62. Global Somatropin Sales Market Share by Application (2019-2024)
Table 63. Global Somatropin Sales Market Share by Application (2025-2030)
Table 64. Global Somatropin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Somatropin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Somatropin Revenue Market Share by Application (2019-2024)
Table 67. Global Somatropin Revenue Market Share by Application (2025-2030)
Table 68. Global Somatropin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Somatropin Price (US$/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Somatropin Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Somatropin Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Eli Lilly and Company Corporation Information
Table 81. Eli Lilly and Company Description and Business Overview
Table 82. Eli Lilly and Company Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly and Company Somatropin Product
Table 84. Eli Lilly and Company Recent Developments/Updates
Table 85. GeneScience Pharmaceuticals Corporation Information
Table 86. GeneScience Pharmaceuticals Description and Business Overview
Table 87. GeneScience Pharmaceuticals Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. GeneScience Pharmaceuticals Somatropin Product
Table 89. GeneScience Pharmaceuticals Recent Developments/Updates
Table 90. Novartis (Sandoz International) Corporation Information
Table 91. Novartis (Sandoz International) Description and Business Overview
Table 92. Novartis (Sandoz International) Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Novartis (Sandoz International) Somatropin Product
Table 94. Novartis (Sandoz International) Recent Developments/Updates
Table 95. Ipsen Corporation Information
Table 96. Ipsen Description and Business Overview
Table 97. Ipsen Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ipsen Somatropin Product
Table 99. Ipsen Recent Developments/Updates
Table 100. LG Life Sciences Corporation Information
Table 101. LG Life Sciences Description and Business Overview
Table 102. LG Life Sciences Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. LG Life Sciences Somatropin Product
Table 104. LG Life Sciences Recent Developments/Updates
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Merck Somatropin Product
Table 109. Merck Recent Developments/Updates
Table 110. Hoffmann-La Roche Corporation Information
Table 111. Hoffmann-La Roche Description and Business Overview
Table 112. Hoffmann-La Roche Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hoffmann-La Roche Somatropin Product
Table 114. Hoffmann-La Roche Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Corporation Information
Table 116. Teva Pharmaceutical Industries Description and Business Overview
Table 117. Teva Pharmaceutical Industries Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Teva Pharmaceutical Industries Somatropin Product
Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
Table 120. Ferring Pharmaceuticals Corporation Information
Table 121. Ferring Pharmaceuticals Description and Business Overview
Table 122. Ferring Pharmaceuticals Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Ferring Pharmaceuticals Somatropin Product
Table 124. Ferring Pharmaceuticals Recent Developments/Updates
Table 125. Anhui Anke Biotechnology Corporation Information
Table 126. Anhui Anke Biotechnology Description and Business Overview
Table 127. Anhui Anke Biotechnology Somatropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Anhui Anke Biotechnology Somatropin Product
Table 129. Anhui Anke Biotechnology Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Somatropin Distributors List
Table 133. Somatropin Customers List
Table 134. Somatropin Market Trends
Table 135. Somatropin Market Drivers
Table 136. Somatropin Market Challenges
Table 137. Somatropin Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Somatropin
Figure 2. Global Somatropin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Somatropin Market Share by Type in 2023 & 2030
Figure 4. Powder Product Picture
Figure 5. Solvent Product Picture
Figure 6. Global Somatropin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Somatropin Market Share by Application in 2023 & 2030
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Somatropin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Somatropin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Somatropin Sales (2019-2030) & (K Units)
Figure 14. Global Somatropin Average Price (US$/Unit) & (2019-2030)
Figure 15. Somatropin Report Years Considered
Figure 16. Somatropin Sales Share by Manufacturers in 2023
Figure 17. Global Somatropin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Somatropin Players: Market Share by Revenue in 2023
Figure 19. Somatropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Somatropin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Somatropin Sales Market Share by Country (2019-2030)
Figure 22. North America Somatropin Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Somatropin Sales Market Share by Country (2019-2030)
Figure 26. Europe Somatropin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Somatropin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Somatropin Revenue Market Share by Region (2019-2030)
Figure 34. China Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Somatropin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Somatropin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Somatropin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Somatropin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Somatropin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Somatropin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Somatropin by Type (2019-2030)
Figure 56. Global Somatropin Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Somatropin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Somatropin by Application (2019-2030)
Figure 59. Global Somatropin Price (US$/Unit) by Application (2019-2030)
Figure 60. Somatropin Value Chain
Figure 61. Somatropin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
